1. The first, vismodegib, was FDA-approved in 2012, for treating basal cell carcinoma. 2. For basal cell cancer, the risk was 1 . 5 time greater. 3. K5 may therefore be useful in the identification of basal cell metastases. 4. Overexpression causes an increase in neuroendocrine, gastric / intestinal and basal cells . 5. This regulatory circuit provides functional control over basal cell proliferation and differentiation. 6. Another 2, 000 will die of basal cell or squamous cell cancers. 7. Basal cell carcinomas rarely spread and deaths from them are rare.8. The olfactory epithelium consists of olfactory sensory cells, sustentacular cells and basal cells . 9. Physical findings typically include follicular atrophoderma, multiple basal cell carcinomas, hypotrichosis, and hypohidrosis. 10. In one study, researchers incorporated tritiated thymidine into dividing murine epidermal basal cells .
Mobile